Consolidated Statement of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Operating activities
Net loss	$ (27,614)	$ (98,465)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	2,657	1,069
Equity-based compensation	20,593	1,033
Change in fair value of warranty liability	(23,188)	61,184
Equity method investment loss	175
Fixed asset write-off	41	56
Issuance of warrants for rent expense		66
Asset retirement obligation accretion		5,504
Amortization of debt issuance costs and discount		671
Accrued payment in kind (“PIK”) interest on debt		4,231
Changes in operating assets and liabilities:
Accounts receivable	298
Other current assets	1,996	(4,074)
Other assets	68	(3,276)
Accounts payable	1,068	1,148
Deferred revenue	(1,588)
Accrued expenses and other liabilities	(92)	1,424
Operating lease right-of-use assets and liabilities	401
Net cash used in operating activities	(25,185)	(29,429)
Investing activities
Capitalization of costs and purchases of network assets, property, and equipment	(1,720)	(857)
Purchase of internal use software	(279)	(197)
Purchase of equity method investments	(1,125)
Purchase of marketable securities	(8,173)
Net cash used in investing activities	(11,297)	(1,054)
Financing activities
Proceeds from senior secured loan		18,467
Proceeds from exercise of stock options	48	2
Repurchase of common stocks (withholding taxes)	(4)
Net cash provided by financing activities	44	18,469
Effect of exchange rates on cash, cash equivalents and restricted cash	(50)	(14)
Net decrease in cash, cash equivalents and restricted cash	(36,488)	(12,028)
Cash, cash equivalents and restricted cash at beginning of period	100,076	13,669
Cash, cash equivalents and restricted cash at end of period	63,588	1,641
Non-cash financing information
Capital expenditure included in accounts payable	427	112
Issuance of warrants		$ 5,504